Impact of diabetes status on immunogenicity of trivalent inactivated influenza vaccine in older adults.
Autorzy:
Spencer S; Influenza Division, US Centers for Disease Control and Prevention, Atlanta, Georgia, USA. Chung JR; Influenza Division, US Centers for Disease Control and Prevention, Atlanta, Georgia, USA. Belongia EA; Center for Clinical Epidemiology & Population Health, Marshfield Clinic Research Institute, Marshfield, Wisconsin, USA. Sundaram M; Center for Clinical Epidemiology & Population Health, Marshfield Clinic Research Institute, Marshfield, Wisconsin, USA. Meece J; Center for Clinical Epidemiology & Population Health, Marshfield Clinic Research Institute, Marshfield, Wisconsin, USA. Coleman LA; Translational Medicine, Novartis Institutes for Biomedical Research, Basel, Switzerland.; Center for Clinical Epidemiology & Population Health, Marshfield Clinic Research Institute, Marshfield, Wisconsin, USA. Zimmerman RK; Schools of Medicine Department of Family Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania, USA. Nowalk MP; Schools of Medicine Department of Family Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania, USA. Moehling Geffel K; Schools of Medicine Department of Family Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania, USA. Ross T; Center for Vaccines and Immunology, Department of Infectious Diseases, University of Georgia, Athens, Georgia, USA.; Schools of Medicine Department of Family Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania, USA. Carter CE; Center for Vaccines and Immunology, Department of Infectious Diseases, University of Georgia, Athens, Georgia, USA.; Schools of Medicine Department of Family Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania, USA. Shay D; Influenza Division, US Centers for Disease Control and Prevention, Atlanta, Georgia, USA. Levine M; Influenza Division, US Centers for Disease Control and Prevention, Atlanta, Georgia, USA. Liepkalns J; Influenza Division, US Centers for Disease Control and Prevention, Atlanta, Georgia, USA.; Department of Biology, University of Washington, Seattle, Washington, USA. Kim JH; Influenza Division, US Centers for Disease Control and Prevention, Atlanta, Georgia, USA.; Translational Medicine, Bristol-Myers Squibb, Princeton, New Jersey, USA. Sambhara S; Influenza Division, US Centers for Disease Control and Prevention, Atlanta, Georgia, USA. Thompson MG; Influenza Division, US Centers for Disease Control and Prevention, Atlanta, Georgia, USA. Flannery B; Influenza Division, US Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies
